What is Infensa Bioscience?
Founded in 2021 and headquartered in North Sydney, Australia, Infensa Bioscience is a biotechnology firm dedicated to pioneering advancements in the prevention of heart attacks and strokes. The company's focus on critical cardiovascular conditions positions it within a vital segment of the healthcare industry, aiming to address significant unmet medical needs through innovative scientific research and development.
How much funding has Infensa Bioscience raised?
Infensa Bioscience has raised a total of $23M across 1 funding round:
Unspecified
$23M
Unspecified (2022): $23M, investors not publicly disclosed
What's next for Infensa Bioscience?
The recent major strategic investment provides Infensa Bioscience with substantial backing to accelerate its research initiatives and potentially scale its operations. This infusion of capital is expected to fuel further development of its preventative therapies, enhance its clinical trial capabilities, and strengthen its market position in the competitive biotechnology landscape. The company is poised to leverage this financing to advance its pipeline and bring its life-saving innovations closer to market.
See full Infensa Bioscience company page
